NO884834L - Disvovelanaloger av ll-e33288-antitumormidler. - Google Patents

Disvovelanaloger av ll-e33288-antitumormidler.

Info

Publication number
NO884834L
NO884834L NO88884834A NO884834A NO884834L NO 884834 L NO884834 L NO 884834L NO 88884834 A NO88884834 A NO 88884834A NO 884834 A NO884834 A NO 884834A NO 884834 L NO884834 L NO 884834L
Authority
NO
Norway
Prior art keywords
disvovel
antitum
analysis
order
disvovel analysis
Prior art date
Application number
NO88884834A
Other languages
English (en)
Other versions
NO173506C (no
NO173506B (no
NO884834D0 (no
Inventor
William James Mcgahren
Martin Leon Sassiver
George A Ellestad
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO884834D0 publication Critical patent/NO884834D0/no
Publication of NO884834L publication Critical patent/NO884834L/no
Publication of NO173506B publication Critical patent/NO173506B/no
Publication of NO173506C publication Critical patent/NO173506C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO884834A 1987-10-30 1988-10-28 Fremgangsmaate ved fremtilling av disvovelanaloger av ll-E33288-antitumormidler NO173506C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11494087A 1987-10-30 1987-10-30

Publications (4)

Publication Number Publication Date
NO884834D0 NO884834D0 (no) 1988-10-28
NO884834L true NO884834L (no) 1989-05-02
NO173506B NO173506B (no) 1993-09-13
NO173506C NO173506C (no) 1993-12-22

Family

ID=22358378

Family Applications (2)

Application Number Title Priority Date Filing Date
NO884833A NO176480C (no) 1987-10-30 1988-10-28 Analogifremgangsmåte ved fremstilling av målrettede former av metyltritio-anti-tumormidler
NO884834A NO173506C (no) 1987-10-30 1988-10-28 Fremgangsmaate ved fremtilling av disvovelanaloger av ll-E33288-antitumormidler

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO884833A NO176480C (no) 1987-10-30 1988-10-28 Analogifremgangsmåte ved fremstilling av målrettede former av metyltritio-anti-tumormidler

Country Status (20)

Country Link
EP (2) EP0313873B1 (no)
JP (2) JP2820256B2 (no)
KR (2) KR970011385B1 (no)
AR (1) AR246083A1 (no)
AT (2) ATE104309T1 (no)
AU (2) AU612714B2 (no)
BR (1) BR1100939A (no)
CA (1) CA1321582C (no)
DE (2) DE3889063T2 (no)
DK (2) DK602488A (no)
ES (2) ES2061586T3 (no)
FI (2) FI91262C (no)
HK (2) HK131997A (no)
IE (2) IE65989B1 (no)
IL (2) IL87946A (no)
NO (2) NO176480C (no)
NZ (2) NZ226726A (no)
PT (2) PT88881B (no)
PY (1) PY0101654A (no)
ZA (2) ZA888127B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5606040A (en) * 1987-10-30 1997-02-25 American Cyanamid Company Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
IL115770A (en) * 1989-04-14 1999-03-12 American Cyanamid Co Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections
GB9007384D0 (en) * 1990-04-02 1990-05-30 Duncan Ruth Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
DE69933044T3 (de) 1998-11-27 2016-11-24 Ucb Pharma, S.A. Zusammensetzungen und verfahren zur erhöhung der knochenmineralisierung
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
EP1636270B1 (en) 2003-06-16 2016-07-20 UCB Pharma S.A. Antibodies specific for sclerostin and methods for increasing bone mineralization
WO2008028050A2 (en) * 2006-08-30 2008-03-06 Wisconsin Alumni Research Foundation Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods
KR100979928B1 (ko) * 2008-07-16 2010-09-03 한주학 수직축형 부력풍차
ES2768611T3 (es) * 2013-11-04 2020-06-23 Pfizer Intermedios y procedimientos para sintetizar derivados de calicheamicina
MX2019008773A (es) * 2017-01-24 2019-09-18 Pfizer Derivados de caliqueamicina y conjugados anticuerpo-farmaco de los mismos.
AU2020221324A1 (en) * 2019-02-15 2021-09-02 University Of Southern California Lym-1 and Lym-2 antibody compositions and improved CAR constructs
EP4234537A4 (en) * 2020-10-22 2024-05-29 FUJIFILM Corporation REAGENT FOR MEASURING SKIN SENSITIZATION, COMPOUND AND METHOD FOR MEASURING SKIN SENSITIZATION

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
DE3175151D1 (en) * 1980-05-21 1986-09-25 Teijin Ltd Reactive polymer and process for the preparation thereof
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
CA1314245C (en) * 1984-05-23 1993-03-09 Franz Jansen Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators
IL76878A (en) * 1984-11-16 1991-12-15 American Cyanamid Co Antitumor antibiotic ll-33288alpha-br complex and process for its preparation
EP0330874A3 (en) * 1988-02-29 1989-10-18 American Cyanamid Company Antibacterial and antitumor agents LL-E33288 epsilon-I and LL-E33288-epsilonBr, with processes and intermediates for producing said agents
EP0342341A3 (en) * 1988-05-17 1991-07-24 American Cyanamid Company Process for producing antitumor antibiotic ll-e33288gamma2

Also Published As

Publication number Publication date
FI91262B (fi) 1994-02-28
HK131997A (en) 1997-10-03
PY0101654A (es) 2002-08-01
FI884984A7 (fi) 1989-05-01
DK602488D0 (da) 1988-10-28
DK602588A (da) 1989-05-01
IE883262L (en) 1989-04-30
CA1321582C (en) 1993-08-24
FI884984A0 (fi) 1988-10-28
IL87946A0 (en) 1989-03-31
AU618763B2 (en) 1992-01-09
EP0313874B1 (en) 1994-04-13
DE3851682T2 (de) 1995-05-04
IL87947A0 (en) 1989-03-31
DE3889063T2 (de) 1994-12-01
NO173506C (no) 1993-12-22
AR246083A1 (es) 1994-03-30
FI95204C (fi) 1996-01-10
EP0313873B1 (en) 1994-09-28
JPH0296599A (ja) 1990-04-09
ATE104309T1 (de) 1994-04-15
BR1100939A (pt) 1999-08-31
NO884833D0 (no) 1988-10-28
PT88881B (pt) 1993-01-29
NO173506B (no) 1993-09-13
NZ226727A (en) 1991-12-23
IE65053B1 (en) 1995-10-04
KR0133130B1 (ko) 1998-04-17
EP0313874A3 (en) 1990-05-09
ZA888127B (en) 1989-07-26
ATE112172T1 (de) 1994-10-15
ES2061586T3 (es) 1994-12-16
DE3889063D1 (de) 1994-05-19
EP0313874A2 (en) 1989-05-03
JP2820256B2 (ja) 1998-11-05
NO176480C (no) 1995-04-12
NO884833L (no) 1989-05-02
NO176480B (no) 1995-01-02
IE65989B1 (en) 1995-11-29
KR890006244A (ko) 1989-06-12
AU612714B2 (en) 1991-07-18
JPH01193282A (ja) 1989-08-03
AU2449488A (en) 1989-05-04
HK131897A (en) 1997-10-03
EP0313873A1 (en) 1989-05-03
IL87946A (en) 1995-06-29
DE3851682D1 (de) 1994-11-03
DK602488A (da) 1989-05-01
NO884834D0 (no) 1988-10-28
FI95204B (fi) 1995-09-29
FI884983A0 (fi) 1988-10-28
IE883261L (en) 1989-04-30
KR890006245A (ko) 1989-06-12
IL87947A (en) 1995-05-26
PT88882B (pt) 1993-01-29
DK174739B1 (da) 2003-10-13
FI91262C (fi) 1994-06-10
ZA888123B (en) 1989-07-26
ES2059464T3 (es) 1994-11-16
FI884983L (fi) 1989-05-01
KR970011385B1 (ko) 1997-07-10
AU2448988A (en) 1989-05-04
JP2720933B2 (ja) 1998-03-04
NZ226726A (en) 1991-08-27
DK602588D0 (da) 1988-10-28

Similar Documents

Publication Publication Date Title
DE3887205D1 (de) Pipette.
KR890700227A (ko) 효소 센서
ES2022975B3 (es) Proceso de elaboracion de alfasemihidrato de calciosulfato.
DK499788D0 (da) Proeveudtagningsudstyr
FI882091A7 (fi) Optinen analyysi.
FI883382A0 (fi) Anvaendning av olefinfoereningar.
DE3883189D1 (de) Trocken-fluessiges analytisches element.
NO884834L (no) Disvovelanaloger av ll-e33288-antitumormidler.
DE3861432D1 (de) Analysengeraet.
DE3768089D1 (de) Prospektionsverfahren.
FI884883A0 (fi) Ny process.
FI880492A0 (fi) Synkroniseringssystem foer en halvdigital signal.
FI870147A0 (fi) Mikrobiologisk framstaellningsmetod.
FI884006L (fi) Hoernfog av vaendraelsar.
DE3852193D1 (de) Trockenes Probenelement.
FI881608A0 (fi) Analysmetod och anordning foer karakterisering av latexer.
FI883671L (fi) Foerfarande foer visuell bestaemning av en analyt.
NO905104D0 (no) Proevetaking av boreslam.
FI861047A7 (fi) Sokeriprosessi.
FI910081A0 (fi) Analys av cellmodifierande substanser.
NO875198D0 (no) Fastfase - analysemetode.
NO880517D0 (no) Biologisk respons-modifiseringsmiddel.
NO901614D0 (no) Luminescens-undersoekelse av enzymer.
KR890011249U (ko) 시료 채수기
DE3886687D1 (de) Digitalisierungsverfahren.

Legal Events

Date Code Title Description
MK1K Patent expired